Middle East Pharmaceutical Industries Company SJSC Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Middle East Pharmaceutical Industries Company SJSC

Watchlist Manager

Watchlist

Price: 121.2 SAR 1.68% Market Closed

Market Cap: ﷼2.4B

M	Middle East Pharmaceutical Industries Company SJSC SAU:4016	SA
H	Hecla Mining Co F:HCL	US
	Supernus Pharmaceuticals Inc NASDAQ:SUPN	US
	Banco Bilbao Vizcaya Argentaria SA MIL:1BBVA	ES
	Iberdrola SA MAD:IBE	ES
	Ageas SA XBRU:AGS	BE
L	Lucara Diamond Corp SWB:LKT	CA
	Datadog Inc (Pre-Reincorporation) NASDAQ:DDOG	US

Profitability Summary

Middle East Pharmaceutical Industries Company SJSC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

62%

Strong 3Y Average Gross Margin

62%

Healthy Operating Margin

24%

Sustainable 3Y Average Operating Margin

23%

Healthy Net Margin

21%

Sustainable 3Y Average Net Margin

20%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Exceptional ROE

26%

Exceptional 3Y Average ROE

27%

Positive ROIC

21%

Positive 3Y Average ROIC

22%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.